Page last updated: 2024-08-23

propiconazole and Intraocular Lymphoma

propiconazole has been researched along with Intraocular Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abedi, F; Borovik, AM; Francis, IC; Hariz, S; Waring, D	1

Other Studies

1 other study(ies) available for propiconazole and Intraocular Lymphoma

Article	Year
Primary intraocular natural killer/T-cell lymphoma unmasked with infective endophthalmitis after an intravitreal injection of bevacizumab. Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:8 Topics: Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Endophthalmitis; Eye Evisceration; Eye Infections, Bacterial; Humans; Intraocular Lymphoma; Intravitreal Injections; Lymphoma, Extranodal NK-T-Cell; Male; Orbit; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A	2019

Article

Year

Primary intraocular natural killer/T-cell lymphoma unmasked with infective endophthalmitis after an intravitreal injection of bevacizumab.

Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:8

Topics: Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Endophthalmitis; Eye Evisceration; Eye Infections, Bacterial; Humans; Intraocular Lymphoma; Intravitreal Injections; Lymphoma, Extranodal NK-T-Cell; Male; Orbit; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Tomography, X-Ray Computed; Vascular Endothelial Growth Factor A

2019